The Japan TimesMar 11
U.S. President Donald Trump’s push for lower U.S. drug prices has unexpectedly helped Astellas Pharma secure higher reimbursement pricing for its new eye medicine in Japan. https://www.japantimes.co.jp/business/2026/03/11/companies/astellas-pharma-drug-prices/?utm_medium=Social&utm_source=mastodon #business #companies #astellaspharma #pharmaceuticals #us #izervay
Trump’s drug cost push helps Astellas win higher price in Japan

Japan, where medicine prices are among the lowest in the most developed nations, has become a critical reference point in U.S. plans to match drug prices with other countries.

The Japan Times